Pulmatrix (NASDAQ:PULM) Stock Price Crosses Below Fifty Day Moving Average – Time to Sell?

Pulmatrix, Inc. (NASDAQ:PULM)’s stock price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $5.72 and traded as low as $4.90. Pulmatrix shares last traded at $4.97, with a volume of 11,205 shares.

Analyst Ratings Changes

Separately, Wall Street Zen began coverage on Pulmatrix in a research report on Tuesday, May 20th. They set a “sell” rating on the stock.

Pulmatrix Stock Performance

The stock has a 50-day moving average of $5.72 and a 200-day moving average of $6.65.

Pulmatrix (NASDAQ:PULM) last released its earnings results on Wednesday, August 6th. The biotechnology company reported ($0.42) earnings per share for the quarter. Pulmatrix had a negative return on equity of 97.25% and a negative net margin of 122.46%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Pulmatrix stock. SBI Securities Co. Ltd. boosted its stake in Pulmatrix, Inc. (NASDAQ:PULM) by 15.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 60,565 shares of the biotechnology company’s stock after purchasing an additional 8,208 shares during the period. SBI Securities Co. Ltd.’s holdings in Pulmatrix were worth $418,000 at the end of the most recent reporting period. 11.84% of the stock is currently owned by institutional investors.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.